Real-time enrollment status for this neoplasms clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:02 PM UTC
| NCT Number | NCT05176665 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 152 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Shanghai EpimAb Biotherapeutics Co., Ltd. |
| Last Updated on CT.gov | August 26, 2024 (Aug 26, 2024) |
As of July 13, 2026: Clinical trial NCT05176665 is currently recruiting participants. This clinical trial study for neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by Shanghai EpimAb Biotherapeutics Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05176665 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05176665 was last updated Aug 26, 2024 (August 26, 2024). HelloStudys verifies this status automatically.